Together we will beat cancer

Donate

Life-extending immunotherapy approved on NHS for children with neuroblastoma

Children in England with high-risk neuroblastoma will now be offered a cancer drug that could extend their life.

Read More

Testing a new immunotherapy treatment for neuroblastoma

A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.

Read More

Long term benefits of immunotherapy emerging for some patients, though key questions remain

A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research.

Read More

Cellular ‘kryptonite’ poses challenges in tackling childhood nerve cancer

Our scientists have discovered that neuroblastoma cells can produce a cellular ‘kryptonite’ that seems to sap the power from nearby immune cells.

Read More

Childhood cancer cells drain immune system’s batteries

Cancer cells in neuroblastoma release a molecule that breaks down a key energy source for the body’s immune cells, leaving them too drained to fight the disease

Read More

Little Star award for inspirational Harley

Manchester youngster Harley Renshaw has had his courage recognised with a special award as he fights cancer in his kidney, neck, lung and bones.

Read More

“It upset me enormously that children were dying, and I wanted to do something to help them” – Andy’s story

Read Professor Andy Pearson’s story, exploring his career researching childhood cancer and what the future holds for the BEACON neuroblastoma trial.

Read More

Simple blood test could improve treatment for deadly childhood cancer

A simple blood test could pinpoint which children are unlikely to respond to treatment for a particularly aggressive form of neuroblastoma

Read More

A groundbreaking clinical trial for children with aggressive neuroblastoma

Neuroblastoma is a type of childhood cancer and our researchers are pioneering new clinical trials to tackle aggressive forms of the disease – how does it work?

Read More

Cancer Research UK launches international trial for treatment of relapsed neuroblastoma

Cancer Research UK scientists and paediatric cancer specialists have launched the BEACON-neuroblastoma trial, which aims to find the best chemotherapy regimen for children and young adults with recurring or resistant neuroblastoma. Researchers will also investigate whether blocking the growth of new blood vessels supplying the tumours can enhance this treatment.

Read More